Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
After finishing at $0.83 in the prior trading day, Atossa Therapeutics Inc (NASDAQ: ATOS) closed at $0.81, down -1.74%. In other words, the price has decreased by -$1.74 from its previous closing price. On the day, 0.62 million shares were traded. ATOS stock price reached its highest trading level at $0.8462 during the session, while it also had its lowest trading level at $0.7916.
Ratios:
Our goal is to gain a better understanding of ATOS by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.17 and its Current Ratio is at 9.17. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Maxim Group on January 26, 2018, initiated with a Buy rating and assigned the stock a target price of $2.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 21 ’25 when QUAY STEVEN C bought 11,239 shares for $0.88 per share. The transaction valued at 9,887 led to the insider holds 13,898 shares of the business. Remmel H. Lawrence bought 10,000 shares of ATOS for $7,000 on Mar 26 ’25. The Director now owns 10,257 shares after completing the transaction at $0.70 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATOS now has a Market Capitalization of 105055120 and an Enterprise Value of 47198120.
Stock Price History:
The Beta on a monthly basis for ATOS is 0.95, which has changed by -0.39416057 over the last 52 weeks, in comparison to a change of 0.15085125 over the same period for the S&P500. Over the past 52 weeks, ATOS has reached a high of $1.62, while it has fallen to a 52-week low of $0.55. The 50-Day Moving Average of the stock is -9.66%, while the 200-Day Moving Average is calculated to be -1.09%.
Shares Statistics:
The stock has traded on average 819.94K shares per day over the past 3-months and 526510 shares per day over the last 10 days, according to various share statistics. A total of 129.17M shares are outstanding, with a floating share count of 129.12M. Insiders hold about 0.04% of the company’s shares, while institutions hold 21.05% stake in the company. Shares short for ATOS as of 1761868800 were 1320496 with a Short Ratio of 1.61, compared to 1759190400 on 2345863. Therefore, it implies a Short% of Shares Outstanding of 1320496 and a Short% of Float of 1.0199999.
Earnings Estimates
Investors are eagerly awaiting the insights provided by 3.0 analysts currently analyzing and rating the stock of Atossa Therapeutics Inc (ATOS).The consensus estimate for the next quarter is -$0.07, with high estimates of -$0.06 and low estimates of -$0.08.
Analysts are recommending an EPS of between -$0.26 and -$0.26 for the fiscal current year, implying an average EPS of -$0.26. EPS for the following year is -$0.28, with 3.0 analysts recommending between -$0.26 and -$0.33.
